Commerce Bank
LGND icon

Commerce Bank’s Ligand Pharmaceuticals LGND Stock Holding History

Commerce Bank’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$671K Sell
2,148
-84
-4% -$24.8K ﹤0.01% 840
2026
Q2 		$706K Buy
2,232
+430
+24% +$101K ﹤0.01% 855
2026
Q1 		$360K Buy
1,802
+494
+38% +$97.7K ﹤0.01% 1060
2025
Q4 		$247K Buy
+1,308
New +$251K ﹤0.01% 1146

Other funds holding LGND

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return

Commerce Bank's LGND Position: Q3 2026 in Review

Commerce Bank reduced its Ligand Pharmaceuticals (LGND) stake by 3.8% in Q3 2026, selling an estimated $24.8K and leaving 2,148 shares worth $671K. The position accounts for ﹤0.01% of the portfolio, ranked #840.

Commerce Bank first reported a position in LGND in Q4 2025 and has held it in 4 quarters since. The position peaked at $706K in Q2 2026. 348 funds tracked by Wall St. Rank hold LGND as of Q3 2026.

  • Commerce Bank held 2,148 shares of Ligand Pharmaceuticals worth $671K as of Q3 2026.
  • Commerce Bank sold 84 Ligand Pharmaceuticals shares in Q3 2026, an estimated $24.8K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Commerce Bank's portfolio in Q3 2026, its #840 holding.
  • Commerce Bank first reported a position in Ligand Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • Commerce Bank's Ligand Pharmaceuticals position peaked at $706K in Q2 2026.
  • 348 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.

Based on Commerce Bank's 13F filing for Q3 2026, filed 12 Nov 2026.